A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumoursAlastair Greystoke, William P. Steward, Sarah P. Blagden et al.|Annals of Oncology|2006Cited by 24
Phase I study of intravenous TZT-1027 (T) and carboplatin (C), administered on Day 1 (T and C) and Day 8 (T) every three weeks in patients (pts) with advanced solid tumorsSarah P. Blagden, W.P. Steward, Gerhardt Attard et al.|Journal of Clinical Oncology|2005Cited by 3